Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN13337022
ISRCTN13337022
Completed
未知

Application of adipose derived mesenchymal stem cells (Ad-MSC) in treating OSTeoarticular and Cartilage lesions

Specialty Hospital St. Catherine0 sites32 target enrollmentFebruary 24, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsKnee osteoarthritisMusculoskeletal Diseases

Overview

Phase
未知
Intervention
Not specified
Conditions
Knee osteoarthritis
Sponsor
Specialty Hospital St. Catherine
Enrollment
32
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2017 results in https://pubmed.ncbi.nlm.nih.gov/29027984/ (added 22/10/2020) 2019 results in https://pubmed.ncbi.nlm.nih.gov/31187950/ (added 23/10/2020) 2019 24 month follow up results in https://pubmed.ncbi.nlm.nih.gov/31861180/ (added 23/10/2020) 2019 sub study in https://pubmed.ncbi.nlm.nih.gov/31234442/ (added 23/10/2020)

Registry
who.int
Start Date
February 24, 2017
End Date
January 18, 2018
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Specialty Hospital St. Catherine

Eligibility Criteria

Inclusion Criteria

  • •1\. Age 40\-85
  • •2\. Knee osteoarthritis (radiological Kellgren and Lawrence grade II\-IV)
  • •3\. Onset of symptoms for more than 6 months in the painful knee
  • •4\. Able to follow the instructions of the study
  • •5\. Signed an informed consent form

Exclusion Criteria

  • •1\. Age less than 40 years or more than 85 years
  • •2\. Chondromatosis or villonodular synovitis of the knee
  • •3\. Recent trauma (\<3 month) of the symptomatic knee
  • •4\. Infectious joint disease
  • •5\. Malignancy
  • •6\. Patients on anticoagulant therapy with PT ( \< 0,70\) or suffering from thrombocytopenia and/or coagulation disorder
  • •7\. Hypersensitivity to local anaesthetic

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Evaluation of mesenchymal stem cells for the treatment of lower back paiower Back PainLower Back PainMusculoskeletal - Other muscular and skeletal disorders
ACTRN12617000636358Magellan Stem Cells10
Recruiting
Not Applicable
The evaluation of mesenchymal stem cells in the treatment of arthritisArthritis
ACTRN12617000638336Melbourne Stem Cell Centre200
Recruiting
Phase 1/2
Adipose-derived mesenchymal stem cells as local treatment of ulcerative colitis
2024-518643-38-00Region Midtjylland16
Recruiting
Phase 1
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
NCT06654193Hope Biosciences LLC70
Withdrawn
Phase 1
ASC Therapy for Patients With Severe Respiratory COVID-19Respiratory Tract Diseases
NCT04341610Rigshospitalet, Denmark